Moolec Net Income From Continuing Ops from 2010 to 2026

MLEC Stock   10.48  1.51  16.83%   
Over recent reporting cycles, Net Loss is dropping amid slightly volatile fluctuations. Compared with the previous period, Net Loss is up roughly 5.26%, supporting projections near approximately -151 M. From 2010 to 2026, the annual regression model for Moolec Science Net Loss reported a median of -4,526,905 . with r-squared of 0.49 . View All Fundamentals
 
Net Loss  
 First Reported
2010-12-31
 Previous Quarter
-159 M
 Current Value
-151 M
 Quarterly Volatility
61.8 M
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Review Moolec Science financial statements over time to add context on performance and capital structure. It connects Depreciation And Amortization of 26.9 M, Other Operating Expenses of 415.5 M or Total Operating Expenses of 150.3 M and ratios such as Price To Sales Ratio of 0.13, Dividend Yield of 0.0 or Days Sales Outstanding of 23.81 with Moolec Science Valuation and Volatility context.
  
Build AI portfolio with Moolec Stock
Review Moolec Science Correlation against competitors for Moolec Science. This provides competitive positioning context.
Analyzing Moolec Science's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Moolec Science's current valuation and future prospects.

Latest Moolec Science's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Moolec Science SA over the last few years. It is Moolec Science's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Moolec Science's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Moolec Net Income From Continuing Ops Regression Statistics

Arithmetic Mean-35,298,006
Coefficient Of Variation-175.05
Mean Deviation 46,733,995
Median-4,526,905
Standard Deviation 61,788,070
Sample Variance3817.8T
Range172.1M
R-Value-0.70
Mean Square Error2083.4T
R-Squared 0.49
Significance 0.0018
Slope-8,550,960
Total Sum of Squares61084.2T

Moolec Net Income From Continuing Ops History

2026-151 M
2025-159 M
2024-176.6 M
2023-7.3 M
2022-51.8 M

About Moolec Science SA Ordinary Shares

Moolec Science SA is scheduled to announce its earnings today. The stock experiences an active upward rally.Moolec Science maintains listing status on the NASDAQ Exchange exchange. The profile for Moolec Science integrates fundamentals, price behavior, and sector exposure. Market-sensitive characteristics amplify cycle exposure. Moolec Science has market cap of 7.61 M, ROE of -1.75%.

Methodology

Unless otherwise specified, financial data for Moolec Science SA is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Moolec (USA Stocks:MLEC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Moolec Science SA is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Moolec Science SA may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

More Resources for Moolec Stock Analysis

A structured review of Moolec Science SA often starts with core financial statements and trend context. Ratios and trend metrics help frame Moolec Science's operating context. Key reports that frame Moolec Science SA Stock are listed below:
Review Moolec Science Correlation against competitors for Moolec Science. This provides competitive positioning context.
Analysis related to Moolec Science should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
 Earnings Share
-308.81
 Revenue Per Share
2.041
 Quarterly Revenue Growth
9.483
 Return On Assets
-0.22
 Return On Equity
-1.75
The market value of Moolec Science SA is measured differently than book value, which reflects Moolec accounting equity. Moolec Science's market capitalization is 7.61 M. A P/B ratio of 1.07 indicates the market values Moolec Science above its accounting book value. Enterprise value stands at 245.46 M. Intrinsic value is an analytical estimate of Moolec Science's underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
Note that Moolec Science's intrinsic value and market price are different measures derived from different inputs. For Moolec Science, key inputs include a P/B ratio of 1.07, ROE of -1.75%, and revenue of 333.61 M. Market price reflects the current exchange level formed by active bids and offers.